Akèy › Ateroskleroz › Tennessee › Knoxville
Etid klinik pou Ateroskleroz nan Knoxville, TN
3 etid pou Ateroskleroz ap chèche patisipan nan sit nan ak bò kote Knoxville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Ap rekriteFaz 3
- Accellacare of Knoxville, Knoxville
- Cardiovascular Research of Knoxville North Knoxville Medical Center, Powell · 8 mi lwen
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Ap rekriteFaz 2/3
- Dialysis Clinic Inc - University Nephology, Knoxville
- Knoxville Kidney Center PLLC, Knoxville
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Ap rekriteFaz 3
- Research Site, Knoxville
- Research Site, Knoxville
- Research Site, Knoxville
- ak 1 plis
Etid Ateroskleroz nan lòt vil
- Boston, MA10 etid
- Houston, TX10 etid
- Washington, DC9 etid
- Hialeah, FL8 etid
- Arlington, VA8 etid
- Orlando, FL8 etid
- Memphis, TN7 etid
- Dallas, TX7 etid
- Durham, NC7 etid
- Miami, FL7 etid
- Las Vegas, NV7 etid
- Minneapolis, MN6 etid
Lòt etid nan Knoxville
- Kansè Poumon ki pa ti selil14 etid
- Obèsite10 etid
- Kansè poumon10 etid
- Kansè nan tete9 etid
- Kansè (tout kalite)8 etid
- Sipwa7 etid
- Ensifizyans kadyak7 etid
- Kansè Metastatik7 etid
- Maladi kadyovaskilè6 etid
- Melanom5 etid
- Dyabèt Tip 25 etid
- Hypertension artérielle5 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.